Marinomed Biotech AG

Director's Dealing • Feb 22, 2019

Publication Date: 22.02.2019 12:54 EANS-DD: Marinomed Biotech AG / Notification concerning transactions by persons performing managerial responsibilities pursuant to article 19 Market Abuse Regulation (MAR)

Directors' Dealings-Announcement pursuant to artikle 19 MAR transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.

personal data:
responsible party:
name: Ute Lassnig (natural person)
--------------------------------------------------------------------------------
reason:
reason: responsible party is a person with managerial responsibilities
function: Member of an administrative or supervisory board
--------------------------------------------------------------------------------
issuer information:
name: Marinomed Biotech AG
Legal Entity Identifier (LEI): 529900GN3B1EN80XF405
--------------------------------------------------------------------------------
information about deal:
ISIN: ATMARINOMED6
description of the financial instrument: Stock
type: conversion ISIN AT000A1WD52
date: 20.02.2019; UTC+01:00
market: WIENER BOERSE AG, XWBO
currency: Euro
 price volume
 40,87 1223
total volume: 1223
total price: 49984,01
average price: 40,87
--------------------------------------------------------------------------------

end of announcement euro adhoc

---

issuer:	Marinomed Biotech AG
	Veterinärplatz 1
	A-1210 Wien
phone:	0043250774460
FAX:	0043250774493
mail:	office@marinomed.com
WWW:	www.marinomed.com
ISIN:	ATMARINOMED6, AT0000A1WD52
indexes:
stockmarkets: Wien
language:	English

	Aussendung übermittelt durch euro adhoc
	The European Investor Relations Service